Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s share price dropped 1% during mid-day trading on Thursday. The stock traded as low as $3.3540 and last traded at $3.3565. 8,725 shares changed hands during mid-day trading, a decline of 35% from the average session volume of 13,521 shares. The stock had previously closed at $3.39.
Medexus Pharmaceuticals Trading Down 1.0%
The company has a 50-day moving average of $3.62 and a 200-day moving average of $3.21.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company focused on acquiring, commercializing and marketing prescription and nonprescription healthcare products in North America. The company works with products that address specialized and underserved therapeutic areas, with operations and commercial activities primarily in the United States and Canada.
Medexus’ portfolio includes IXINITY, a recombinant factor IX therapy used for the treatment and prevention of bleeding in people with hemophilia B.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
